PFIZER INC (1PFE.MI) Stock Price & Overview
BIT:1PFE • US7170811035
Current stock price
The current stock price of 1PFE.MI is 23.76 EUR. Today 1PFE.MI is up by 2.72%. In the past month the price increased by 7.51%. In the past year, price decreased by -3.75%.
1PFE.MI Key Statistics
- Market Cap
- 135.106B
- P/E
- 8.49
- Fwd P/E
- 9.18
- EPS (TTM)
- 2.80
- Dividend Yield
- 6.40%
1PFE.MI Stock Performance
1PFE.MI Stock Chart
1PFE.MI Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to 1PFE.MI. When comparing the yearly performance of all stocks, 1PFE.MI turns out to be only a medium performer in the overall market: it outperformed 45.25% of all stocks.
1PFE.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to 1PFE.MI. While 1PFE.MI is still in line with the averages on profitability rating, there are concerns on its financial health.
1PFE.MI Earnings
On February 3, 2026 1PFE.MI reported an EPS of 0.66 and a revenue of 17.56B. The company beat EPS expectations (14.29% surprise) and beat revenue expectations (2.56% surprise).
1PFE.MI Forecast & Estimates
35 analysts have analysed 1PFE.MI and the average price target is 24.82 EUR. This implies a price increase of 4.45% is expected in the next year compared to the current price of 23.76.
For the next year, analysts expect an EPS growth of -7.56% and a revenue growth -1.41% for 1PFE.MI
1PFE.MI Groups
Sector & Classification
1PFE.MI Financial Highlights
Over the last trailing twelve months 1PFE.MI reported a non-GAAP Earnings per Share(EPS) of 2.8. The EPS increased by 3.86% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 12.42% | ||
| ROA | 3.73% | ||
| ROE | 8.99% | ||
| Debt/Equity | 0.71 |
1PFE.MI Ownership
1PFE.MI Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| SNW | SANOFI | 8.96 | 185.977B | ||
| SAN | SANOFI | 8.98 | 185.711B | ||
| 1SAN | SANOFI | 8.95 | 184.552B | ||
| UNC | UCB SA | 25.32 | 50.65B | ||
| UCB | UCB SA | 24.68 | 50.164B | ||
| 1MRK | MERCK KGAA | 13.45 | 48.348B | ||
| MRK | MERCK KGAA | 13.23 | 48.217B | ||
| BAYN | BAYER AG-REG | 8.45 | 39.503B | ||
| 1BAYN | BAYER AG-REG | 8.44 | 38.825B | ||
| IPN | IPSEN | 12.71 | 13.217B | ||
| TUB | FINANCIERE DE TUBIZE | N/A | 9.681B | ||
| REC | RECORDATI INDUSTRIA CHIMICA | 15.58 | 9.419B | ||
| VIRP | VIRBAC SA | 16.39 | 2.806B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Milan Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About 1PFE.MI
Company Profile
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The company is headquartered in New York City, New York and currently employs 75,000 full-time employees. The firm is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment includes the Pfizer U.S. Commercial Division, and the Pfizer International Commercial Division. Its product categories include oncology, primary care and specialty care. Its oncology products include Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak and Talzenna. Its primary care products include Eliquis, Nurtec ODT/Vydura, Zavzpret, the Prevnar family, Comirnaty, Abrysvo, FSME/IMMUN-TicoVac, Nimenrix, Trumenba, and Paxlovid. Its specialty care products include Xeljanz, Enbrel (outside the United States and Canada), Inflectra, Abrilada, Cibinqo, Litfulo, Eucrisa, Velsipity, the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, Hympavzi, Sulperazon, Zavicefta, Octagam and others.
Company Info
IPO: 1944-01-17
PFIZER INC
66 Hudson Boulevard East
New York City NEW YORK US
Employees: 75000
Phone: 13026587581
PFIZER INC / 1PFE.MI FAQ
What does PFIZER INC do?
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The company is headquartered in New York City, New York and currently employs 75,000 full-time employees. The firm is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment includes the Pfizer U.S. Commercial Division, and the Pfizer International Commercial Division. Its product categories include oncology, primary care and specialty care. Its oncology products include Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak and Talzenna. Its primary care products include Eliquis, Nurtec ODT/Vydura, Zavzpret, the Prevnar family, Comirnaty, Abrysvo, FSME/IMMUN-TicoVac, Nimenrix, Trumenba, and Paxlovid. Its specialty care products include Xeljanz, Enbrel (outside the United States and Canada), Inflectra, Abrilada, Cibinqo, Litfulo, Eucrisa, Velsipity, the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, Hympavzi, Sulperazon, Zavicefta, Octagam and others.
What is the stock price of PFIZER INC today?
The current stock price of 1PFE.MI is 23.76 EUR. The price increased by 2.72% in the last trading session.
Does 1PFE stock pay dividends?
PFIZER INC (1PFE.MI) has a dividend yield of 6.4%. The yearly dividend amount is currently 1.5.
How is the ChartMill rating for PFIZER INC?
1PFE.MI has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
What is the GICS sector and industry of 1PFE stock?
PFIZER INC (1PFE.MI) operates in the Health Care sector and the Pharmaceuticals industry.
How is the valuation of PFIZER INC (1PFE.MI) based on its PE ratio?
The PE ratio for PFIZER INC (1PFE.MI) is 8.49. This is based on the reported non-GAAP earnings per share of 2.8 and the current share price of 23.76 EUR.
What is the expected growth for 1PFE stock?
The Revenue of PFIZER INC (1PFE.MI) is expected to decline by -1.41% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.